Table 1. Demographics and Baseline Characteristics.
Characteristic | Standard of care | Home healtha |
---|---|---|
Age | ||
Participants, No. | 19 | 23 |
Mean (SD), y | 64.1 (10.0) | 65.0 (10.9) |
Sex, No. (%) | ||
Male | 11 (58) | 13 (57) |
Female | 8 (42) | 10 (43) |
Time since Parkinson disease diagnosis | ||
Participants, No. | 19 | 23 |
Mean (SD), y | 11.5 (7.2) | 12.0 (5.9) |
Race, No. (%) | ||
White | 19 (100) | 21 (91) |
African American | 0 | 2 (9) |
Ethnicity, No. (%) | ||
Hispanic or Latino | 1 (5) | 3 (13) |
Not Hispanic or Latino | 18 (95) | 20 (87) |
Deep brain stimulation target, No. (%) | ||
Subthalamic nucleus | 3 (16) | 5 (22) |
Globus pallidus internus | 16 (84) | 18 (78) |
No. of deep brain stimulation leads, No. (%) | ||
Unilateral | 11 (58) | 12 (52) |
Bilateral | 8 (42) | 11 (48) |
Total UPDRS off-medication scoreb | ||
Participants, No. | 18 | 23 |
Mean (SD) | 46.8 (14.0) | 60.1 (20.3) |
Off-levodopa/on-levodopa responsec | ||
Participants, No. | 19 | 23 |
Mean (SD), % | 31.0 (24.0) | 37.0 (21.0) |
UPDRS III off-medication scorec | ||
Participants, No. | 19 | 23 |
Mean (SD) | 33.5 (9.4) | 40.5 (12.9) |
UPDRS III on-medication scorec | ||
Participants, No. | 19 | 23 |
Mean (SD) | 23.2 (10.9) | 25.3 (11.9) |
PDQ-39 score | ||
Participants, No. | 18 | 23 |
Mean (SD) | 21.2 (22.5) | 33.6 (21.2) |
Levodopa equivalent daily dose, mg | ||
Participants, No. | 11 | 14 |
Mean (SD) | 1104.0 (579.7) | 1174.6 (612.7) |
Caregivers enrolled, No. (%) | 14 (74) | 22 (96) |
Multidimensional Caregiver Strain Index score | ||
Participants, No. | 12 | 21 |
Mean (SD) | 12.7 (13.8) | 16.1 (12.6) |
Abbreviations: PDQ-39, 39-question Parkinson’s Disease Questionnaire; UPDRS, Unified Parkinson’s Disease Rating Scale; UPDRS III, Unified Parkinson’s Disease Rating Scale part III.
Patients in the home health arm had slightly more parkinsonism, as indicated by the higher mean total UPDRS and UPDRS III off-medication scores.
The total UPDRS is the sum of parts I, II, III, and IV.
Preoperative baseline used.